[News Brief] HSA and Indonesia FDA Sign Regulatory Cooperation MOU
The Health Sciences Authority (HSA) of Singapore and the Indonesian Food and Drug Authority (Indonesian FDA) have signed a Memorandum…
Pharmaceuticals & Supplements
[News Brief] Sanofi’s Tzield Accepted for Priority Review in the US for Young Children with Stage 2 Type 1 Diabetes
Sanofi has announced that the US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics licence…
[News Brief] Takeda Releases Phase 3 Data for Zasocitinib in Plaque Psoriasis
Takeda has published results from its Phase 3 clinical trials for Zasocitinib, an oral treatment for moderate-to-severe plaque psoriasis. This…
[News Brief] Lunit and Daiichi Sankyo Partner for AI‑Driven Biomarker Discovery and Translational Oncology Research
Lunit has announced a collaboration with Daiichi Sankyo to advance research in AI‑driven biomarker discovery and translational oncology. This summary…
[News Brief] Linaprazan Glurate Included in China’s National Reimbursement List
Cinclus Pharma Holding AB’s drug linaprazan glurate has been included in China’s 2025 National Reimbursement Drug List (NRDL) ahead of…
[News Brief] Gushengtang Launches 10 AI Avatars of Renowned Traditional Chinese Medicine Practitioners
Gushengtang has introduced 10 AI avatars modelled on renowned Traditional Chinese Medicine (TCM) experts as part of its ongoing integration…
[News Brief] UF, Duke‑NUS and BRIN Establish Global Marine Natural Products Partnership
The University of Florida’s Centre for Natural Products, Drug Discovery and Development (CNPD3) has formed a trilateral research partnership with…
[News Brief] Maersk Opens First Bonded Warehouse in North Vietnam
A.P. Moller – Maersk has opened its first own‑licensed bonded warehouse in Northern Vietnam, located at SLP Park, Nam Dinh…
[News Brief] ChemLex Secures USD 45M to Launch Self-Driving Lab in Singapore
ChemLex, an AI-for-science startup, has raised USD 45 million in seed funding to launch a self-driving laboratory for drug discovery…
[News Brief] Hyphens Pharma Out-licenses Cerapro® MED to European Markets
Hyphens Pharma Pte. Ltd. has entered into an out-licensing agreement for its skin barrier cream, Cerapro® MED Skin Barrier Cream,…